These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16135636)

  • 21. Glycine serum level in schizophrenia: relation to negative symptoms.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Doubek P; Libiger J
    Psychiatry Res; 2010 Apr; 176(2-3):103-8. PubMed ID: 20096465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry.
    Baruah S; Waziri R; Hegwood TS; Mallis LM
    Psychiatry Res; 1991 Jun; 37(3):261-70. PubMed ID: 1679949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
    Umbricht D; Alberati D; Martin-Facklam M; Borroni E; Youssef EA; Ostland M; Wallace TL; Knoflach F; Dorflinger E; Wettstein JG; Bausch A; Garibaldi G; Santarelli L
    JAMA Psychiatry; 2014 Jun; 71(6):637-46. PubMed ID: 24696094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperhomocysteinemia and schizophrenia: case control study].
    Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
    Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
    Weiser M; Heresco-Levy U; Davidson M; Javitt DC; Werbeloff N; Gershon AA; Abramovich Y; Amital D; Doron A; Konas S; Levkovitz Y; Liba D; Teitelbaum A; Mashiach M; Zimmerman Y
    J Clin Psychiatry; 2012 Jun; 73(6):e728-34. PubMed ID: 22795211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
    Heresco-Levy U; Javitt DC
    Schizophr Res; 2004 Feb; 66(2-3):89-96. PubMed ID: 15061240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated homocysteine levels in young male patients with schizophrenia.
    Levine J; Stahl Z; Sela BA; Gavendo S; Ruderman V; Belmaker RH
    Am J Psychiatry; 2002 Oct; 159(10):1790-2. PubMed ID: 12359692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.
    Shim SS; Hammonds MD; Kee BS
    Eur Arch Psychiatry Clin Neurosci; 2008 Feb; 258(1):16-27. PubMed ID: 17901997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid patterns in schizophrenia: some new findings.
    Macciardi F; Lucca A; Catalano M; Marino C; Zanardi R; Smeraldi E
    Psychiatry Res; 1990 Apr; 32(1):63-70. PubMed ID: 2161549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Naveen MN; Thirthall J; Gangadhar BN; Shetty KT
    Am J Psychiatry; 2007 Oct; 164(10):1557-60. PubMed ID: 17898347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
    Tsai G; Lane HY; Yang P; Chong MY; Lange N
    Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic effects on serine and glycine metabolism.
    Baruah S; Waziri R; Sherman A
    Biol Psychiatry; 1993 Oct; 34(8):544-50. PubMed ID: 7903868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study.
    van Berckel BN; Evenblij CN; van Loon BJ; Maas MF; van der Geld MA; Wynne HJ; van Ree JM; Kahn RS
    Neuropsychopharmacology; 1999 Aug; 21(2):203-10. PubMed ID: 10432468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.